Drug Trial Radar · NCT05014568
Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults
Last checked: Nov 20, 2026Latest source record: Sep 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
407
Actual
Start
Sep 1, 2021
Primary completion
Mar 30, 2023
Study completion Apr 7, 2023
Sponsor
- Lead sponsor
- Organon and CoIndustry
- Sponsor type
- Industry
- First posted
- Aug 20, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.
Conditions
- Atopic Dermatitis
Interventions
tapinarof cream, 1%Drug
applied topically once daily
Vehicle creamDrug
applied topically once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Subjects Who Have a Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) Score of Clear or Almost Clear (0 or 1) With a Minimum 2-grade Improvement From Baseline to Week 8. Analyses Were Done Using Multiple Imputation.Time frame: Baseline to Week 8
Locations
67 sites in 2 countries. Site status is shown where the registry gives one.
Dermavant Investigative Site
Birmingham, Alabama
Dermavant Investigative Site
Phoenix, Arizona
Dermavant Investigative Site
Bryant, Arkansas
Dermavant Investigative Site
Beverly Hills, California
Dermavant Investigative Site
Fountain Valley, California
Dermavant Investigative Site
Fremont, California
Dermavant Investigative Site
Inglewood, California
Dermavant Investigative Site
Los Angeles, California
Dermavant Investigative Site
Los Angeles, California
Dermavant Investigative Site
Mission Viejo, California
Dermavant Investigative Site
Sacramento, California
Dermavant Investigative Site
Washington D.C., District of Columbia
Dermavant Investigative Site
Boca Raton, Florida
Dermavant Investigative Site
Boca Raton, Florida
Dermavant Investigative Site
Brandon, Florida
Dermavant Investigative Site
Coral Gables, Florida
Dermavant Investigative Site
Jacksonville, Florida
Dermavant Investigative Site
Margate, Florida
Dermavant Investigative Site
Miami, Florida
Dermavant Investigative Site
Miami Lakes, Florida
Dermavant Investigative Site
Orlando, Florida
Dermavant Investigative Site
Pinellas Park, Florida
Dermavant Investigative Site
Sweetwater, Florida
Dermavant Investigative Site
Tampa, Florida
Dermavant Investigative Site
Marietta, Georgia
Dermavant Investigative Site
Sandy Springs, Georgia
Dermavant Investigative Site
Savannah, Georgia
Dermavant Investigative Site
Plainfield, Indiana
Dermavant Investigative Site
Louisville, Kentucky
Dermavant Investigative Site
Owensboro, Kentucky
Dermavant Investigative Site
Covington, Louisiana
Dermavant Investigative Site
Monroe, Louisiana
Dermavant Investigative Site
Largo, Maryland
Dermavant Investigative Site
Bay City, Michigan
Dermavant Investigative Site
Clarkston, Michigan
Dermavant Investigative Site
Warren, Michigan
Dermavant Investigative Site
Ypsilanti, Michigan
Dermavant Investigative Site
New Brighton, Minnesota
Dermavant Investigative Site
Missoula, Montana
Dermavant Investigative Site
Omaha, Nebraska
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.